Search results
Results: 99
Number of items: 99
-
Schilt, T., de Win, M. M., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., & Schmand, B. (2008). No evidence of decrease in cognitive function in users of low-dose ecstasy - Reply. Archives of General Psychiatry, 65(2), 236-237. http://archpsyc.ama-assn.org/cgi/content/full/65/2/236-a
-
Ooteman, W., Koeter, M. W. J., Verheul, R., Schippers, G. M., & van den Brink, W. (2007). The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. European Neuropsychopharmacology, 17(8), 558-566. https://doi.org/10.1016/j.euroneuro.2007.02.012
-
Schilt, T., de Win, M. M. L., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., & Schmand, B. A. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64(6), 728-736. https://doi.org/10.1001/archpsyc.64.6.728
-
Vervaeke, H. K. E., Korf, D. J., Benschop, A., & van den Brink, W. (2007). How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context. Addictive Behaviors, 32(8), 1705-1713. https://doi.org/10.1016/j.addbeh.2006.11.008
-
Reneman, L., Schilt, T., de Win, M. M., Booij, J., Schmand, B., van den Brink, W., & Bakker, O. (2006). Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology, 20(3), 389-399. https://doi.org/10.1177/0269881106063266
Page 8 of 10